Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.

BACKGROUND: Octreotide treatment may be associated with gall stone development in up to 50% of patients with acromegaly. Two new sustained-release formulations of somatostatin analogue have been recently developed: lanreotide SR (Somatuline) and octreotide LAR (Sandostatin LAR). The incidence of gal...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Turner, H, Lindsell, DR, Vadivale, A, Thillainayagam, A, Wass, J
स्वरूप: Journal article
भाषा:English
प्रकाशित: 1999